Catalyst Pharmaceuticals, Inc.
CPRX
$24.79
$0.552.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 37.02% | 55.97% | 73.76% | 87.06% | 276.03% |
| Total Receivables | 94.31% | 83.29% | 15.77% | 19.17% | 23.04% |
| Inventory | 90.19% | 40.03% | 3.53% | -0.88% | 24.91% |
| Prepaid Expenses | -13.05% | 35.57% | -11.96% | 4.18% | 66.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 303.76% | 588.41% | 20.68% | -70.50% | 43.87% |
| Total Current Assets | 43.36% | 58.16% | 59.93% | 69.48% | 184.33% |
|
|
|||||
| Total Current Assets | 43.36% | 58.16% | 59.93% | 69.48% | 184.33% |
| Net Property, Plant & Equipment | -17.08% | -16.14% | -10.14% | -9.36% | -3.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -15.96% | -22.51% | -21.31% | -20.24% | -19.26% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.76% | -0.45% | 27.11% | 25.98% | 25.83% |
| Total Assets | 29.66% | 36.22% | 37.59% | 40.55% | 81.11% |
|
|
|||||
| Total Accounts Payable | -32.49% | -21.34% | -22.32% | 9.12% | 12.15% |
| Total Accrued Expenses | 14.50% | 25.44% | 34.01% | 40.24% | 33.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.71% | 8.91% | 8.83% | 8.75% | 8.94% |
| Total Finance Division Other Current Liabilities | 48.21% | 29.38% | 21.71% | 47.45% | 141.77% |
| Total Other Current Liabilities | 48.21% | 29.38% | 21.71% | 47.45% | 141.77% |
| Total Current Liabilities | 21.94% | 22.15% | 22.41% | 40.32% | 58.66% |
|
|
|||||
| Total Current Liabilities | 21.94% | 22.15% | 22.41% | 40.32% | 58.66% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.65% | -14.81% | -14.01% | -13.26% | -12.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -33.65% | -94.22% | -87.10% | -90.07% | -89.44% |
| Total Liabilities | 20.95% | 18.27% | 18.61% | 34.39% | 50.52% |
|
|
|||||
| Common Stock & APIC | 8.52% | 9.67% | 9.14% | 8.52% | 65.95% |
| Retained Earnings | 66.29% | 94.91% | 112.58% | 136.53% | 135.14% |
| Treasury Stock & Other | -- | -- | -- | -- | 357.14% |
| Total Common Equity | 31.15% | 39.23% | 40.64% | 41.48% | 87.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.15% | 39.23% | 40.64% | 41.48% | 87.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.15% | 39.23% | 40.64% | 41.48% | 87.59% |
|
|
|||||